IBA57
Iron-sulfur cluster assembly factor IBA57, mitochondrial
Also known as: C1orf69, CAF17_HUMAN, FLJ12734
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5T440
- Gene
- IBA57
- Ensembl
- ENSG00000181873
- Chromosome
- 1
- Canonical length
- 356 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
The protein encoded by this gene localizes to the mitochondrion and is part of the iron-sulfur cluster assembly pathway. The encoded protein functions late in the biosynthesis of mitochondrial 4Fe-4S proteins. Defects in this gene have been associated with autosomal recessive spastic paraplegia-74 and with multiple mitochondrial dysfunctions syndrome-3. Two transcript variants encoding different isoforms have been found for this gene. The smaller isoform is not likely to be localized to the mitochondrion since it lacks the amino-terminal transit peptide. [provided by RefSeq, Jul 2015]
Canonical amino-acid sequenceUniProt
356 residues, UniProt reviewed canonical sequence.
>Q5T440|IBA57
1 MATAALLRGA TPGRGGPVWR WRLRAAPRCR LAHSSCSPGG DPTAGAAWAC FRLDGRTLLR
61 VRGPDAAPFL LGLLTNELPL PSPAAAGAPP AARAGYAHFL NVQGRTLYDV ILYGLQEHSE
121 VSGFLLECDS SVQGALQKHL ALYRIRRKVT VEPHPELRVW AVLPSSPEAC GAASLQERAG
181 AAAILIRDPR TARMGWRLLT QDEGPALVPG GRLGDLWDYH QHRYLQGVPE GVRDLPPGVA
241 LPLESNLAFM NGVSFTKGCY IGQELTARTH HMGVIRKRLF PVRFLDPLPT SGITPGATVL
301 TASGQTVGKF RAGQGNVGLA LLWSEKIKGP LHIRASEGAQ VALAASVPDW WPTVSKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IBA57 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 5.6 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 5.6 nTPM
- bone marrow: 3.9 nTPM
- tongue: 3.7 nTPM
- heart muscle: 3.1 nTPM
- skin: 2.8 nTPM
- adrenal gland: 2.7 nTPM
Single-cell type
- late spermatids: 48 nCPM
- early spermatids: 24 nCPM
- late primary spermatocytes: 23 nCPM
- syncytiotrophoblasts: 18 nCPM
- colonocytes: 15 nCPM
- esophageal basal cells: 15 nCPM
Immune cell
- basophil: 1.6 nTPM
- MAIT T-cell: 1 nTPM
- plasmacytoid DC: 0.9 nTPM
- NK-cell: 0.8 nTPM
- naive CD4 T-cell: 0.7 nTPM
- naive CD8 T-cell: 0.7 nTPM
Brain region
- white matter: 9.8 nTPM
- cerebellum: 9.6 nTPM
- thalamus: 8.9 nTPM
- medulla oblongata: 8.7 nTPM
- amygdala: 8.6 nTPM
- cerebral cortex: 8.5 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about IBA57.
Disease | AllUniProt
Conditions IBA57 is implicated in, by any mechanism.
- Multiple mitochondrial dysfunctions syndrome 3 (MMDS3) MIM:615330
- Spastic paraplegia 74, autosomal recessive (SPG74) MIM:616451
Disease | GeneticClinVar
39 pathogenic / likely-pathogenic of 345 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Multiple mitochondrial dysfunctions syndrome 3
- Hereditary spastic paraplegia 74
- Inborn genetic diseases
- IBA57-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.96
- gnomAD pLI
- 0.01
- gnomAD missense Z
- -0.57
- DepMap mean gene effect
- -0.22
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Aminomethyltransferase superfamily
- YgfZ/CAF17, C-terminal
- YgfZ/GcvT
- CAF17, C-terminal domain
- CAF17, C-terminal beta-barrel domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IBA57 as an antibody target. Whether an autoantibody or antibody against IBA57 could matter depends on whether native IBA57 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IBA57 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label IBA57 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...